Loading...

AKRO AKERO THERAPEUTICS INC Management Changes 8-K Filing

KR T

KR

AKERO THERAPEUTICS INC

(AKRO)

2025 8-K

Show Summary

Show Summary

Financial Statements

Financial Results

Clinical Study Results

Financial Results

Financial Results Announcement

Annual Meeting of Stockholders

Financial Results Announcement

Warrant Issuance

Underwriting Agreement

HARMONY Study Results

Financial Results Announcement

Phase 3 Clinical Study Anno...

Financial Results Announcement

Financial Results Announcement

Annual Meeting of Stockholders

Financial Update

Underwriting Agreement

Financial Results Announcement

FDA Meeting and Phase 3 Pro...

Open Market Sale Agreement

Financial Results Announcement

External Links:

On June 3, 2025, Akero Therapeutics, Inc. held its Annual Meeting where stockholders elected two directors, ratified the appointment of Deloitte & Touche LLP as auditors, and approved executive compensation. Votes included 46.7 million for Judy Chou

AI Assistant

AKERO THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.